EvoRadar
Pricing
AI BrainIdeasDice
2295 ideas0 HOT526 WARM1769 COLD
© 2026 Kisum GmbH·ImpressumDatenschutzSubprocessorsAGBVerträge hier kündigen·GitHub
EvoRadar — AI-Discovered Startup Opportunitiesevoradar.ai
© 2026 Kisum GmbHevoradar.ai · Generated by EvoRadar
← BackWatch AI Discovery

Pediatric Cochlear Coaching for Otarmeni-Treated Children

COLD✧ v82 May 2026

AI Thinking Process

Pass 1 conviction: 47%. Passed initial screening and advanced to deepening phase.

Kill type: FEATURE_COLLAPSE. Conviction dropped from 47% to 22%. Cochlear Ltd and Eli Lilly (Akouos parent) both have 6-12 month credible paths to ship this as a bundled feature — Cochlear through existing AVT-therapist relationships at every target academic medical center, Eli Lilly through the drug + companion app patient-support infrastructure. The 50-baby/year US TAM does not generate enough switching-cost gravity to defend a standalone tool against either bundled offer.

Kill Reason

Cochlear Ltd and Eli Lilly (Akouos parent) both have 6-12 month credible paths to ship this as a bundled feature — Cochlear through existing AVT-therapist relationships at every target academic medical center, Eli Lilly through the drug + companion app patient-support infrastructure. The 50-baby/year US TAM does not generate enough switching-cost gravity to defend a standalone tool against either bundled offer.

Risk Analysis

Risk analysis available for latest engine ideas.

What do you think?

Related ideas you can explore free:

COLDConsumer FCRA Employment AI Screening Dispute Tool

killed: Three compounding factors: (1) CFPB guidance (Circular 2024-06) was rescinded in 2025 — the regulatory foundation is weaker than assumed; (2) Legal void problem: until courts rule whether AI hiring tools are consumer reporting agencies under FCRA, a dispute tool is filing disputes that screening companies may legally ignore; (3) Historical near-duplicate of 'Employment Screening FCRA Dispute Kit' (20260323-crossdomain, COLD) — the CFPB guidance rescission provides a stronger kill reason than the original.

COLDCosmetics Reformulation Competitive Intelligence

killed: Template offspring of today's CPG Reformulation Intelligence Platform (G056). Same data source approach (public ingredient databases + web scraping), same mechanism (automated diff detection). Different buyer segment (cosmetics regulatory affairs vs. CPG competitive intelligence) but not a new product — a market expansion path for the same company.

COLDAI Layoff AI-Washing Evidence Service for Employment Lawyers

killed: AI-washing of layoffs may be a 2025-2026 narrative phenomenon, not a structural market. Per-lawyer frequency (5-20 AI-washing cases/year) makes SaaS unviable — per-report pricing ($500-2,000) is consulting, not software. G028 crisis signal trap applies.